Checkmate Pharmaceuticals Inc

NASDAQ:CMPI   3:59:54 PM EDT
6.15
-0.33 (-5.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Checkmate Pharmaceuticals Inc Stock, NASDAQ:CMPI

245 Main Street, 2nd floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.682.3625
Number of Employees: 25

Description

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod (CMP-001), is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.